Pancreatic Ductal Adenocarcinoma Is Profoundly Inhibited By CDK4/6 Inhibitors

被引：0
|
作者：
Wachsmann, Megan [1 ]
Borja, Nicholas [1 ]
Balaji, Uthra [1 ]
Knudsen, Erik [1 ]
Witkiewicz, Agnes [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1804
引用
收藏
页码：451A / 451A
页数：1
相关论文
共 50 条
  • [1] Pancreatic Ductal Adenocarcinoma Is Profoundly Inhibited By CDK4/6 Inhibitors
    Wachsmann, Megan
    Borja, Nicholas
    Balaji, Uthra
    Knudsen, Erik
    Witkiewicz, Agnes
    MODERN PATHOLOGY, 2015, 28 : 451A - 451A
  • [2] Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21
    Mortoglou, Maria
    Miralles, Francesc
    Mould, Rhys Richard
    Sengupta, Dipankar
    Uysal-Onganer, Pinar
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2023, 102 (02)
  • [3] CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
    Salvador-Barbero, Beatriz
    Alvarez-Fernandez, Monica
    Zapatero-Solana, Elisabet
    El Bakkali, Aicha
    del Camino Menendez, Maria
    Lopez-Casas, Pedro P.
    Di Domenico, Tomas
    Xie, Tao
    VanArsdale, Todd
    Shields, David J.
    Hidalgo, Manuel
    Malumbres, Marcos
    CANCER CELL, 2020, 37 (03) : 340 - +
  • [4] Cotargeting MEK and CDK4/6 to treat pancreatic adenocarcinoma
    Maust, Joel D.
    Simeone, Diane
    Sebolt-Leopold, Judith
    CANCER RESEARCH, 2016, 76
  • [5] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [6] CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma
    Cheng, Ke
    Zhou, Zijian
    Chen, Qiangxing
    Chen, Zixin
    Cai, Yu
    Cai, He
    Wu, Shangdi
    Gao, Pan
    Cai, Yunqiang
    Zhou, Jin
    Wang, Xin
    Wu, Zhong
    Peng, Bing
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [7] Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma
    Willobee, Brent A.
    Gaidarski, Alexander A.
    Dosch, Austin R.
    Castellanos, Jason A.
    Dai, Xizi
    Mehra, Siddharth
    Messaggio, Fanuel
    Srinivasan, Supriya
    VanSaun, Michael N.
    Nagathihalli, Nagaraj S.
    Merchant, Nipun B.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (07) : 1246 - 1256
  • [8] CDK4/6 inhibitors prolong OS
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) : 722 - 722
  • [9] CDK4/6 inhibitors: The Devil is in the Detail
    Magge, Tara
    Rajendran, Sneha
    Brufsky, Adam M.
    Foldi, Julia
    CURRENT ONCOLOGY REPORTS, 2024, 26 (06) : 665 - 678
  • [10] Development and strategies of CDK4/6 inhibitors
    Chen, Pingping
    Xu, Yinqiu
    Li, Xuanyi
    Yao, Hequan
    Lin, Kejiang
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (02) : 127 - 145
12345